Talal Hilal, M.D., is a hematologist/oncologist and bone marrow transplant physician with a clinical focus on chronic lymphocytic leukemia, lymphoid malignancies, and rare histiocytic neoplasms. Dr. Hilal attended medical school at the Royal College of Surgeons in Ireland. He obtained training in internal medicine at the University of Kentucky and in hematology/oncology at the Mayo Clinic in Phoenix, Arizona where he served as Chief Fellow.

Dr. Hilal's clinical practice focuses on the treatment of chronic lymphocytic leukemia, various types of lymphoma, and histiocytic neoplasms. He is interested in incorporating various modalities of therapy that help serve individual patient needs, including using novel targeted therapies, bispecific T-cell engagers, and cellular therapy.

He is part of the bone marrow transplant and chimeric antigen receptor (CAR) T-cell therapy programs where he prescribes specialized treatments for patients with lymphoid malignancies.